Motivational Therapy for Psychotic Patients: A Comprehensive Analysis

This report examines the application of motivational therapy (MT) in treating psychotic disorders, with a particular focus on schizophrenia and related conditions. It highlights the challenges of medication adherence and the potential of motivational interviewing (MI) to improve patient outcomes. The report references studies demonstrating the effectiveness of MI in enhancing medication adherence and increasing patient engagement in therapy. It emphasizes the patient-centered approach of MT, which prioritizes the patient's autonomy and goals. By exploring the benefits of MI, the report underscores its potential for integration into mental health care programs to improve treatment efficacy and patient well-being. The report also references the study by Fiszdon et al. (2015), which indicates a strong correlation between MI and improved adherence to medication in schizophrenic patients.

Running head: MOTIVATIONAL THERAPY FOR PSYCHOTIC PATIENTS
MOTIVATIONAL THERAPY FOR PSYCHOTIC PATIENTS
Name of the Student
Name of the University
Author note

1
MOTIVATIONAL THERAPY FOR PSYCHOTIC PATIENTS
Psychotic mental disorder are complex disease, which causes abnormal perceptions and
thinking. The main symptoms are misunderstandings related to false beliefs or misperceptions
regarding some people. Other one is hallucinations such s seeing, hearing, or feeling that is not
there. One of the psychotic disorder is Schizophrenia. This disorder requires cooperative
methodology to detect, diagnose, treat and recover the patient. Schizophrenic spectrum disorders
such as schizoaffective disorder, schizophreniform and schizophrenia constitutes 60 to 70
percent psychotic population under treatment of mental health services. The use of oral drugs
during acute or chronic stages of illness to reduce symptoms of psychotic functioning is
accepted. However, clinical trial of such drug showed poor results (Chien et al., 2015).
Non-adherence to medication decreases the effects drugs used in clinical trials and use of
resources. Therefore, use of Motivational therapy (MT) or motivational interviewing helps the
mental health carers while treating treatment resistant schizophrenia. The adaptation and
assessment of motivational therapy need to be used among patient with such spectrum of disease.
This process is a direct and person-to-person approach to activate motivation and to
explore contradictions to understand the patient’s mental health. Key component of MT
conversation is to let the patient understand his problems and to let him find solutions himself.
The healthcare expert uses their knowledge and skills to direct the process in right direction
taking into account the goals of patient and maintaining his autonomy (Christie & Channon,
2014)
According to the experimental study by Fiszdon et al. (2015), motivational interviewing
can be used to make the patient adapt to the medication to increase the adherence and task-
specific motivation. The experiential relationship between these MI and session attendance

2
MOTIVATIONAL THERAPY FOR PSYCHOTIC PATIENTS
suggests that these session helped patients to increase adherence to medication. This process uses
less technology and is very easy to perform without interfering with the autonomy of the patient.
It can be easily incorporated into the care program to treat such patient perhaps in other mental
disorder cases as well.

3
MOTIVATIONAL THERAPY FOR PSYCHOTIC PATIENTS
Reference
Chien, W. T., Mui, J. H., Cheung, E. F., & Gray, R. (2015). Effects of motivational interviewing-
based adherence therapy for schizophrenia spectrum disorders: a randomized controlled
trial. Trials, 16(1), 270.
Christie, D., & Channon, S. (2014). The potential for motivational interviewing to improve
outcomes in the management of diabetes and obesity in paediatric and adult populations:
a clinical review. Diabetes, Obesity and Metabolism, 16(5), 381-387.
Fiszdon, J. M., Kurtz, M. M., Choi, J., Bell, M. D., & Martino, S. (2015). Motivational
interviewing to increase cognitive rehabilitation adherence in
schizophrenia. Schizophrenia bulletin, 42(2), 327-334.